Literature DB >> 2408285

The parasympathetic neuroeffector junction of the heart.

K Löffelholz, A J Pappano.   

Abstract

This review has directed attention to the anatomical, biochemical, physiological, and pharmacological features of cardiac parasympathetic neuroeffector transmission. The relationships among these properties have permitted a synthesis of the operation of the parasympathetic nervous system at the subcellular, cellular, tissue, and organ level in the heart. However, the attempt to obtain a comprehensive model of parasympathetic neuroeffector transmission in the heart has not only unmasked many features of junctional activity that are poorly understood, but also indicated significant gaps between in vitro and in vivo experimental situations.

Mesh：

Substances：

Year:  1985        PMID： 2408285

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


  88 in total

1.  S100A1: a regulator of myocardial contractility.

Authors:  P Most; J Bernotat; P Ehlermann; S T Pleger; M Reppel; M Börries; F Niroomand; B Pieske; P M Janssen; T Eschenhagen; P Karczewski; G L Smith; W J Koch; H A Katus; A Remppis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Pyridostigmine blunts the increases in myocardial oxygen demand elicited by the stimulation of the central nervous system in anesthetized rats.

Authors:  A Grabe-Guimarães; L M Alves; E Tibiriçá; A C Nóbrega
Journal:  Clin Auton Res       Date:  1999-04       Impact factor: 4.435

Review 3.  Muscarinic regulation of cardiac ion channels.

Authors:  Robert D Harvey; Andriy E Belevych
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 4.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

5.  Effects of vagal stimulation and applied acetylcholine on the arrested sinus venosus of the toad.

Authors:  R A Bywater; G D Campbell; F R Edwards; G D Hirst
Journal:  J Physiol       Date:  1990-06       Impact factor: 5.182

6.  Interactive effects of isoprenaline, forskolin and acetylcholine on Ca2+ current in frog ventricular myocytes.

Authors:  R Fischmeister; A Shrier
Journal:  J Physiol       Date:  1989-10       Impact factor: 5.182

7.  Cyclic AMP metabolism in intact rat ventricular cardiac myocytes: interaction of carbachol with isoproterenol and 3-isobutyl-1-methylxanthine.

Authors:  Y Katano; M Endoh
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

8.  Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia.

Authors:  K M Braas; V May; S A Harakall; J C Hardwick; R L Parsons
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels.

Authors:  S Herzig; A Meier; M Pfeiffer; J Neumann
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

10.  Genetic disruption of G proteins, G(i2)alpha or G(o)alpha, does not abolish inotropic and chronotropic effects of stimulating muscarinic cholinoceptors in atrium.

Authors:  P Boknik; S Grote-Wessels; G Barteska; M Jiang; F U Müller; W Schmitz; J Neumann; L Birnbaumer
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.